Fractyl Health, Inc. Common Stock

NASDAQ:GUTS

Biotechnology

Healthcare
$4.16 -0.81%

-$0.01 today

Market cap
$55.18M
Beta
2.34
P/E (TTM)
-0.6
EPS (TTM)
-$1.42
52W Low $0.38High $2.45

Volume 0.10M

Average 2.07M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$90.33M

FY 2025 · Annual

Investing Cash Flow

-$557,000.00

FY 2025 · Annual

Financing Cash Flow

$104.96M

FY 2025 · Annual

+3.7% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(38.74M)(46.45M)(77.09M)(68.69M)(140.95M)
Depreciation & Amortization676K452K286K677K1.13M
Deferred Income Tax00000
Stock-Based Compensation2.09M3.14M4.3M14.43M6.68M
Change in Working Capital1.71M(1.24M)989K9.59M(395K)
Accounts Receivables00(22K)22K0
Inventory00(73K)073K
Accounts Payables666K0(427K)2.69M(1.67M)
Other Working Capital1.05M(1.24M)1.51M6.88M1.2M
Other Non-Cash Items795K(2.14M)28.7M(21.52M)43.21M
Operating Cash Flow(33.46M)(46.24M)(42.82M)(65.52M)(90.33M)
Capital Expenditures(51K)(56K)(359K)(1.77M)(557K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(51K)(56K)(359K)(1.77M)(557K)
Debt Repayment(7K)4.03M28.35M(187K)(457K)
Common Stock Issued0321K0103.7M105.42M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities40K0(911K)(2.28M)0
Financing Cash Flow99.88M4.35M27.44M101.23M104.96M
Effect of Forex Changes0(4.26M)000
Net Change in Cash66.37M(46.2M)(15.75M)33.94M14.08M
Free Cash Flow(33.51M)(46.3M)(43.18M)(67.29M)(90.89M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$141.0M
+ D&A$1.1M
+ Stock-Based Comp$6.7M
+ Deferred Tax$0
- Working Capital-$395.0K
+ Other Non-Cash$43.2M
= Operating Cash Flow-$90.3M
- Capex-$557.0K
= Free Cash Flow-$90.9M

Analysis

FY2025 free cash flow is -$90.9M. FCF conversion is 64.5% of net income. Operating cash flow was -$90.3M, with capex of -$557.0K. The largest bridge item is Other Non-Cash at $43.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 24, 2026
4Statement of changes in beneficial ownershipSep 16, 2026
8-KCurrent reportSep 11, 2026
DEF 14ADEF 14A filingAug 24, 2026
PRE 14APRE 14A filingAug 14, 2026

Does GUTS generate free cash flow?

Fractyl Health, Inc. Common Stock (GUTS) generated -$90.89M of free cash flow in fiscal 2025.

How much operating cash flow does GUTS produce?

Operating cash flow was -$90.33M, before capital expenditures of $557,000.00.